Citizens above the age of 45 wait to receive a dose of the Covid-19 vaccine at a centre in Mumbai. (PTI)
Citizens above the age of 45 wait to receive a dose of the Covid-19 vaccine at a centre in Mumbai. (PTI)

Co-Win chief explains when booking for vaccines will start for people above 18 years

Private and state government hospitals which were part of the first and the second phase of the vaccination drive need not to get on Co-Win separately, RS Sharma said.
By | Edited by Poulomi Ghosh
PUBLISHED ON APR 29, 2021 11:27 PM IST

As booking for Covid-19 vaccinations for people between 18 and 44 years has not yet started ever after 24 hours of the beginning of the registration on, Co-win chief and the CEO of National Health Authority RS Sharma said it completely depends on the state governments and the private hospitals.

"The platform is ready with all kind of options," Sharma said.

Explaining that the process for private hospitals and the state government hospitals to get on board is nothing new, Sharma said, "Hospitals which conducted vaccination in the previous phases are already there on the platform. They do not need to get on the platform separately. They will have to just inform which days they will function for which age groups and which vaccines they will administer."

"New hospitals can also get on Co-Win easily. Our immunisation officers facilitate the process," Sharma said adding that on Thursday, there have been more than 90 lakh registrations.

Registration on Co-Win began on April 28 but people were not able to book appointments as the hospitals on the platforms are only showing slots for people above the age of 45 years.

Several states, including Maharashtra, Punjab, Gujarat, Andhra Pradesh and Delhi, on Thursday, said they may miss the launch date as they do not have the adequate vaccine storage to expand the ongoing drive.

In the third phase, the Centre has allowed the state governments and private hospitals to procure vaccines directly from the vaccine manufacturers. Both Serum Institute of India and Bharat Biotech have revised per dose vaccine price and brought it down after the Centre asked the vaccine makers to reconsider the prices. For a dose of Serum's Covishield, state governments will now have to pay 300, while for Bharat Biotech's Covaxin, states will have to pay 400.

Story Saved